Efficacy and safety of artificial liver support system treatment for immune checkpoint inhibitors related liver failure in patients with hepatocellular carcinoma: Protocol for a randomized controlled clinical trial
This clinical trial has been registered on ClinicalTrials.gov with the identifier NCT05484908 (Release Date: July 30, 2022) (https://clinicaltrials.gov/study/NCT05484908).
Authors
- Yeqiong Zhang (ORCID: https://orcid.org/0000-0003-2324-8570)
- Qiumin Luo
- Liang Peng (ORCID: https://orcid.org/0000-0001-6184-5750)
- Xiyao Chen (ORCID: https://orcid.org/0009-0003-7315-2427)
- Jiadi Lai
- Wenxiong Xu (ORCID: https://orcid.org/0000-0002-0671-697X)
- Zhexuan Deng
- Zhipeng Li (ORCID: https://orcid.org/0000-0002-0355-7889)
- Ying Liu (ORCID: https://orcid.org/0000-0003-0165-8157)
- Jia Chen (ORCID: https://orcid.org/0000-0002-7096-1056)
- Chan Xie (ORCID: https://orcid.org/0000-0001-6344-9380)
Institutions
- Sun Yat-sen University (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e39095
- Citations
- 4
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.48
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University
- Natural Science Foundation of Guangdong Province
- Guangzhou Municipal Science and Technology Project